A clinical trial, conducted by an international team of researchers and co-led by Charité – Universitätsmedizin Berlin, has shown that a triple combination therapy consisting of three known compounds is both safe and effective in cystic fibrosis…
Eating at the wrong time of day disrupts our circadian rhythm and increases the risk of obesity and type 2 diabetes. The team led by PD Dr. Olga Ramich of DIfE, Professor Achim Kramer and Professor Andreas F. H. Pfeiffer of Charité –…
ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of the agreement is yet another milestone in a series of fruitful…
Björn von Siemens is co-founder and managing director of caresyntax GmbH. The company develops algorithms that analyze risk factors during surgery and provide decision support. The company, based in Berlin and Boston, recently raised 100 million US…
Berlin, 2 August 2021. Eckert & Ziegler (ISIN DE0005659700, TecDAX) acquired Ambientis Radioproteção, based in Sao Paulo, Brazil, effective July 31st, 2021 via its subsidiary Eckert & Ziegler Brasil Isotope Solutions Ltda (EZBIS). The business with…
BIOMONITOR IIIm Received Frost & Sullivan’s ‘Enabling Technology Leadership Award’ 2021 for its High Precision Cardiac Monitoring
– Seventure Partners and Novartis Pharmaceuticals join as new investors
– Transformative treatment for millions of children with myopia
Berlin, Germany, July 14, 2021 — Dopavision, a company pioneering the development of digital therapeutics,…
Berlin, Germany and Duarte, USA, June 9, 2021:
ProBioGen AG has announced a commercial product license agreement with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening…
The purpose of this EU survey is to gain understanding on the needs of companies/organisations in the EU working on the development of new and repurposed medicines for COVID-19 therapeutics, i.e. medicines specifically developed for an indication…
SPARK Europe will be regularly featured on the podcast series BioInnovation Spotlight “Shining a Light on The Next Big Thing“, a podcast series produced for and with LifeScience ORG.
Dr. Felix Lorenz, SPARKee and founder of the Berlin-based…
